WMJ : official publication of the State Medical Society of Wisconsin · 2025
Hepatitis C in Wisconsin Jails: Barriers to Testing and Treatment During Incarceration.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hacker Emily, Mitchell Kailynn, Mohr Caroline
Аннотация
BACKGROUND: Justice-involved individuals are disproportionately affected by hepatitis C virus (HCV) infection. Wisconsin's viral hepatitis elimination plan prioritizes this population, yet little is known about jail capacity for testing and treatment.
METHODS: A 10-item survey was emailed to administrators of 71 county jails and 1 Tribal detention facility to assess HCV testing and treatment practices and barriers. Responses were analyzed descriptively.
RESULTS: Thirty facilities (41.7%) responded. Ten jails (33.3%) offered HCV testing; 15 (51.7%) provided treatment. Common barriers to testing included lack of contracted services (40%) and staffing constraints (23.3%). Barriers to treatment included financial restrictions (66.7%) and short incarceration periods (33.3%).
DISCUSSION: Limited testing and treatment capacity persists despite Medicaid coverage and effective therapies.
CONCLUSIONS: Partnerships with local health agencies and policy changes addressing cost and contractual limitations are essential to expand HCV services in Wisconsin jails.
METHODS: A 10-item survey was emailed to administrators of 71 county jails and 1 Tribal detention facility to assess HCV testing and treatment practices and barriers. Responses were analyzed descriptively.
RESULTS: Thirty facilities (41.7%) responded. Ten jails (33.3%) offered HCV testing; 15 (51.7%) provided treatment. Common barriers to testing included lack of contracted services (40%) and staffing constraints (23.3%). Barriers to treatment included financial restrictions (66.7%) and short incarceration periods (33.3%).
DISCUSSION: Limited testing and treatment capacity persists despite Medicaid coverage and effective therapies.
CONCLUSIONS: Partnerships with local health agencies and policy changes addressing cost and contractual limitations are essential to expand HCV services in Wisconsin jails.